Alexis R Miranda, Joanne G Patterson, Devin LaPolt, Ruva P Rumano, Alexa M Reynoso, Micah L Berman, Brittney L Keller-Hamilton, Megan E Roberts, Amy K Ferketich, Patricia J Zettler
{"title":"A Call for Regulatory Clarity: \"Switch\" and \"Quit Smoking\" Marketing among Online Disposable E-Cigarette Sellers.","authors":"Alexis R Miranda, Joanne G Patterson, Devin LaPolt, Ruva P Rumano, Alexa M Reynoso, Micah L Berman, Brittney L Keller-Hamilton, Megan E Roberts, Amy K Ferketich, Patricia J Zettler","doi":"10.54111/0001/iii1","DOIUrl":null,"url":null,"abstract":"FDA generally regulates products containing nicotine under its tobacco authorities, unless those products are intended for smoking cessation—in which case, they are regulated as drugs that must be FDA-approved as safe and effective. Accordingly, for e-cigarettes, questions arise about where the line is between a tobacco product intended merely for recreational use and a drug product intended for smoking cessation. Against this background, this Research Letter describes a content analysis of certain claims made by 28 online e-cigarette retailers and argues that our findings suggest a need for additional regulatory clarity about when e-cigarettes are appropriately regulated as smoking cessation drug-delivery devices rather than tobacco products.","PeriodicalId":73196,"journal":{"name":"Harvard public health review (Cambridge, Mass.)","volume":"61 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243603/pdf/nihms-1904298.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harvard public health review (Cambridge, Mass.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54111/0001/iii1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
FDA generally regulates products containing nicotine under its tobacco authorities, unless those products are intended for smoking cessation—in which case, they are regulated as drugs that must be FDA-approved as safe and effective. Accordingly, for e-cigarettes, questions arise about where the line is between a tobacco product intended merely for recreational use and a drug product intended for smoking cessation. Against this background, this Research Letter describes a content analysis of certain claims made by 28 online e-cigarette retailers and argues that our findings suggest a need for additional regulatory clarity about when e-cigarettes are appropriately regulated as smoking cessation drug-delivery devices rather than tobacco products.